Unknown

Dataset Information

0

Automated Quantification of Macular Ellipsoid Zone Intensity in Glaucoma Patients: the Method and its Comparison with Manual Quantification.


ABSTRACT: The macular ellipsoid zone intensity (mEZi) is a known marker of disease severity in a number of diverse ocular diseases. The purpose of this study was to establish an automated method (AM) for mEZi quantification and to compare the method's performance with that of a manual method (MM) for glaucoma patients and healthy controls. Seventy-one (71) mild-to-moderate glaucoma patients, 71 severe-glaucoma patients, and 51 controls were enrolled. Both calibration (n?=?160) and validation (n?=?33) image sets were compiled. The correlation of AM to MM quantification was assessed by Deming regression for the calibration set, and a compensation formula was generated. Then, for each image in the validation set, the compensated AM quantification was compared with the mean of five repetitive MM quantifications. The AM quantification of the calibration set was found to be linearly correlated with MM in the normal-to-severe-stage glaucoma patients (R2?=?0.914). The validation set's compensated AM quantification produced R2?=?0.991, and the relationship between the 2 quantifications was AM?=?1.004(MM)?+?0.139. In the validation set, the compensated AM quantification fell within MM quantification's 95% confidence interval in 96.9% of the images. An AM for mEZi quantification was calibrated and validated relative to MM quantification for both glaucoma patients and healthy controls.

SUBMITTER: Ha A 

PROVIDER: S-EPMC6930206 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Automated Quantification of Macular Ellipsoid Zone Intensity in Glaucoma Patients: the Method and its Comparison with Manual Quantification.

Ha Ahnul A   Sun Sukkyu S   Kim Young Kook YK   Jeoung Jin Wook JW   Kim Hee Chan HC   Park Ki Ho KH  

Scientific reports 20191224 1


The macular ellipsoid zone intensity (mEZi) is a known marker of disease severity in a number of diverse ocular diseases. The purpose of this study was to establish an automated method (AM) for mEZi quantification and to compare the method's performance with that of a manual method (MM) for glaucoma patients and healthy controls. Seventy-one (71) mild-to-moderate glaucoma patients, 71 severe-glaucoma patients, and 51 controls were enrolled. Both calibration (n = 160) and validation (n = 33) imag  ...[more]

Similar Datasets

| S-EPMC10362918 | biostudies-literature
| S-EPMC7192485 | biostudies-literature
| S-EPMC6785352 | biostudies-literature
| S-EPMC10789205 | biostudies-literature
| S-EPMC6024664 | biostudies-literature
| S-EPMC8357338 | biostudies-literature
| S-EPMC9315074 | biostudies-literature
| S-EPMC5317200 | biostudies-other
| S-EPMC9440143 | biostudies-literature
| S-EPMC7190172 | biostudies-literature